1064 studies found for:    "Glioblastoma"
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component;   Recurrent Glioblastoma;   Relapsed Glioblastoma
Interventions: Drug: Bevacizumab;   Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: KLH
2 Active, not recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: Temozolomide;   Drug: KLH
3 Not yet recruiting Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme;   GBM;   Brain Cancer
Interventions: Drug: VAL-083;   Drug: Lomustine
4 Active, not recruiting Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
Conditions: Glioblastoma Multiforme;   Glioblastoma
Intervention: Biological: Single arm, open-label
5 Terminated Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme
Intervention: Drug: FDOPA PET
6 Recruiting Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma - Category
Interventions: Drug: Bevacizumab;   Procedure: Magnetic Resonance Spectroscopy (MRS);   Procedure: Border Zone Stereotactic Radiosurgery (BZ-SRS)
7 Active, not recruiting Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma
Interventions: Biological: bevacizumab;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Genetic: microarray analysis;   Genetic: DNA methylation analysis
8 Recruiting Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Glioma;   Astrocytoma;   Brain Tumor
Interventions: Biological: Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy;   Biological: Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
9 Recruiting Ph I Personalized NeoAntigen Cancer Vaccine With Radiotherapy for Patients With MGMT Unmethylated, Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   MGMT-unmethylated Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Features;   Giant Cell Glioblastoma;   Glioblastoma Multiforme
Interventions: Radiation: Radiation Therapy;   Biological: Personalized NeoAntigen Vaccine
10 Recruiting NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: Bevacizumab;   Device: NovoTTF-l00A;   Other: Quality of Life Assessment
11 Completed Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
Conditions: Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma
Interventions: Drug: XL184;   Drug: temozolomide;   Radiation: Radiation Therapy
12 Recruiting Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Conditions: Adult Brain Glioblastoma;   Glioblastoma Multiforme
Interventions: Biological: SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose);   Drug: Bevacizumab
13 Active, not recruiting A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Conditions: Glioblastoma;   GBM;   Glioblastoma Multiforme
Interventions: Drug: Ascorbate;   Drug: Temozolomide;   Radiation: Radiation therapy
14 Recruiting Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
Conditions: Glioblastoma;   Glioblastoma Multiforme
Intervention: Procedure: MRI
15 Active, not recruiting PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Conditions: Glioblastoma;   GBM;   Glioblastoma Multiforme
Intervention: Drug: PF-00299804
16 Not yet recruiting TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Glioblastoma;   Malignant Glioma;   GBM
Interventions: Drug: Bevacizumab;   Device: Optune;   Other: Brain MRI;   Other: Quality of Life Questionnaires
17 Active, not recruiting PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
Conditions: Glioblastoma;   Cancer of Brain and Nervous System;   Glioblastoma Multiforme
Interventions: Drug: Temozolomide;   Procedure: Stereotactic Radiosurgery
18 Not yet recruiting Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma;   Malignant Glioma;   Astrocytoma, Grade IV;   GBM
Interventions: Biological: pp65 DC with GM-CSF;   Biological: Influenza DC with GM-CSF;   Biological: PBMC with GM-CSF;   Drug: Td;   Drug: Saline
19 Completed Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Gliosarcoma
Interventions: Drug: enzastaurin;   Drug: temozolomide;   Radiation: radiation
20 Completed Measuring Non-Enhancing Glioblastoma Progression
Conditions: Brain Tumor;   Glioblastoma
Intervention: Procedure: MRI/MRS Scan

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years